Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProAir HFA BAI in pediatric asthma
NCT00308685Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jun 2006
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of albuterol spiromax in asthma, sponsored by Teva Pharmaceutical Industries Ltd.. Started Jun 2006; status: completed.
02
Drugs
albuterol spiromax
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00308685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308685.